|
1 Indications And Usage Symfi ® (Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate) Is Indicated As A Complete Regimen For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 40 Kg. Symfi Is A Three-Drug Combination Of Efavirenz (Efv), A Non-Nucleoside Reverse Transcriptase Inhibitor, And Lamivudine (3tc) And Tenofovir Disoproxil Fumarate (Tdf), Both Nucleo(T)side Reverse Transcriptase Inhibitors And Is Indicated As A Complete Regimen For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 40 Kg. ( 1 )
|